topic

A gene expression assay for simultaneous measurement of microsatellite instability and anti-tumor immune activity
Patrick Danaher, Sarah Warren, SuFey Ong, Nathan Elliott, Alessandra Cesano, Sean Ferree

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 15; DOI: 10.1186/s40425-018-0472-1
Distinct tumor microenvironments of lytic and blastic bone metastases in prostate cancer patients
Claire L. Ihle, Meredith D. Provera, Desiree M. Straign, E. Erin Smith, Susan M. Edgerton, Adrie Van Bokhoven, M. Scott Lucia, Philip Owens

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 293; DOI: 10.1186/s40425-019-0753-3
NKG2D signaling certifies effector CD8 T cells for memory formation
Cynthia Perez, Kushal Prajapati, Brianna Burke, Lourdes Plaza-Rojas, Nancy J. Zeleznik-Le, Jose A. Guevara-Patino

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 48; DOI: 10.1186/s40425-019-0531-2
TLR9 acts as a sensor for tumor-released DNA to modulate anti-tumor immunity after chemotherapy
Tae Heung Kang, Chih-Ping Mao, Young Seob Kim, Tae Woo Kim, Andrew Yang, Brandon Lam, Ssu-Hsueh Tseng, Emily Farmer, Yeong-Min Park, Chien-Fu Hung

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 260; DOI: 10.1186/s40425-019-0738-2
Two roads for oncolytic immunotherapy development
Howard L. Kaufman, Praveen K. Bommareddy

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 26; DOI: 10.1186/s40425-019-0515-2
New generation of DNA-based immunotherapy induces a potent immune response and increases the survival in different tumor models
Alessandra Lopes, Chiara Bastiancich, Mathilde Bausart, Sophie Ligot, Laure Lambricht, Kevin Vanvarenberg, Bernard Ucakar, Bernard Gallez, Véronique Préat, Gaëlle Vandermeulen

Journal for ImmunoTherapy of Cancer Apr 2021, 9 (4) e001243; DOI: 10.1136/jitc-2020-001243
Rapid corticosteroid taper versus standard of care for immune checkpoint inhibitor induced nephritis: a single-center retrospective cohort study
Meghan D Lee, Harish Seethapathy, Ian A Strohbehn, Sophia H Zhao, Genevieve M Boland, Riley Fadden, Ryan Sullivan, Kerry L Reynolds, Meghan E Sise

Journal for ImmunoTherapy of Cancer Apr 2021, 9 (4) e002292; DOI: 10.1136/jitc-2020-002292
Control of PD-L1 expression in CLL-cells by stromal triggering of the Notch-c-Myc-EZH2 oncogenic signaling axis
Martin Böttcher, Heiko Bruns, Simon Völkl, Junyan Lu, Elisavet Chartomatsidou, Nikos Papakonstantinou, Kristin Mentz, Maike Büttner-Herold, Thorsten Zenz, Marco Herling, Wolfgang Huber, Paolo Ghia, Kostas Stamatopoulos, Andreas Mackensen, Dimitrios Mougiakakos

Journal for ImmunoTherapy of Cancer Apr 2021, 9 (4) e001889; DOI: 10.1136/jitc-2020-001889
Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants
Alessandra Dondero, Martina Morini, Davide Cangelosi, Katia Mazzocco, Martina Serra, Grazia Maria Spaggiari, Gianluca Rotta, Annalisa Tondo, Franco Locatelli, Aurora Castellano, Francesca Scuderi, Angela Rita Sementa, Alessandra Eva, Massimo Conte, Alberto Garaventa, Cristina Bottino, Roberta Castriconi

Journal for ImmunoTherapy of Cancer Apr 2021, 9 (4) e002293; DOI: 10.1136/jitc-2020-002293
CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation
Ryan Michael Reyes, Yilun Deng, Deyi Zhang, Niannian Ji, Neelam Mukherjee, Karen Wheeler, Harshita B Gupta, Alvaro S Padron, Aravind Kancharla, Chenghao Zhang, Myrna Garcia, Anand V R Kornepati, Onur Boyman, Jose R Conejo-Garcia, Robert S Svatek, Tyler J Curiel

Journal for ImmunoTherapy of Cancer Apr 2021, 9 (4) e002051; DOI: 10.1136/jitc-2020-002051

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages